Microdosing is also harder with oral GLP-1s
In the past month, President Trump has announced several prescription drug pricing deals between his administration and different drugmakers, including deals with Pfizer and AstraZeneca related to what they charge state Medicaid programs for some of their drugs, and a subsequent deal with a maker of in vitro fertilization (IVF) drugs aimed at lowering the cost of these treatments
Polycystic ovary syndrome management: a review of the possible amazing role of berberine
Semaglutide Both Tirzepatide and Semaglutide are helpful for weight loss and blood sugar control
With millions of Americans already taking GLP-1 medications and use continuing to grow, these effects on preventing and treating substance use disorders could have significant impact at the population level
Semaglutide may be the right starting point if you: Are new to GLP-1 therapy and want to start with the most established option Have a moderate amount of weight to lose Don't have significant insulin resistance or type 2 diabetes Want a well-documented safety profile with years of real-world data Tirzepatide may be the stronger option if you: Have a higher BMI or significant amount of weight to lose Have insulin resistance, prediabetes, or type 2 diabetes Have tried Semaglutide previously with limited results Want the most aggressive metabolic intervention currently available Are dealing with significant visceral fat or metabolic syndrome The Most Important Factor: Medical Guidance The right medication is the one your provider determines is appropriate for your health history, labs, BMI, and goals not the one that sounds more advanced or that someone else is using
